Texas

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Luminex, a developer of molecular diagnostics and clinical tools for the life sciences industry, returned to profit this quarter – well ahead of schedule – after a major client, LabCorp, departed in 2019.

The protein, called a nicotinic receptor, has been a challenge to study since it sits in the cell’s membrane.

Companies strengthen their leadership teams and executive boards with this week’s Movers & Shakers.

“The adjustments we have made to our studies reflect our foremost concern for the safety and well-being of study participants, clinical investigators and their site staffs, our employees and communities as we face this challenging and unpredictable operating environment,” said Warren Huff, Reata’s chief executive officer and president.

BioSpace takes a quick look at some recent, key industry news that is not related to the coronavirus.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2020. We want to know how the coronavirus outbreak may be impacting your work and your workplace.

Cell Medica has rebranded itself as Kuur Therapeutics as it dives into the development of anti-cancer therapies using its innovative chimeric antigen receptor natural killer T cell therapy platform.

The company’s founder and chief executive officer, Ravi Srinivasan, took time to speak with BioSpace to discuss the company and its technology platform.